We are live on ! Find out more
Vanguard Fiduciary Trust

Vanguard Fiduciary Trust Portfolio holdings

AUM $454B
This Fund
S&P 500
This Quarter Est. Return
+25.89%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$454B
AUM Growth
+$58.2B
Cap. Flow
+$1.07B
Cap. Flow %
0.24%
Top 10 Hldgs %
29.47%
Holding
4,173
New
110
Increased
2,643
Reduced
1,032
Closed
97

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$401M
2
AAPL icon
Apple
AAPL
+$206M
3
MSFT icon
Microsoft
MSFT
+$175M
4
AMZN icon
Amazon
AMZN
+$173M
5
CTRA
Coterra Energy
CTRA
+$149M

Sector Composition

Rank Sector Weight
1 Technology 34.13%
2 Financials 13.36%
3 Industrials 10.07%
4 Healthcare 9.55%
5 Consumer Discretionary 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDZN icon
3951
Roadzen
RDZN
$128M
$27.9K ﹤0.01%
+19,077
New +$30.3K
CVKD icon
3952
Cadrenal Therapeutics
CVKD
$6.28M
$27.8K ﹤0.01%
8,311
CETX icon
3953
Cemtrex
CETX
$5.2M
$27.7K ﹤0.01%
+9,120
New +$74.7K
AIMD icon
3954
Ainos
AIMD
$10.5M
$27.5K ﹤0.01%
14,169
OXBR icon
3955
Oxbridge Re Holdings
OXBR
$11.1M
$27.4K ﹤0.01%
26,649
XCUR icon
3956
Exicure
XCUR
$8.8M
$27.4K ﹤0.01%
13,161
IHT
3957
InnSuites Hospitality Trust
IHT
$15M
$27.4K ﹤0.01%
16,092
RMCF icon
3958
Rocky Mountain Chocolate Factory
RMCF
$12.9M
$27.2K ﹤0.01%
30,507
CNTB
3959
Connect Biopharma Holdings
CNTB
$157M
$26.9K ﹤0.01%
+11,314
New +$27.4K
HIND
3960
Vyome Holdings
HIND
$15.9M
$26.2K ﹤0.01%
12,195
NXTC icon
3961
NextCure
NXTC
$35.3M
$25.8K ﹤0.01%
16,134
+119
+0.7% +$880
TWAV
3962
TaoWeave Inc
TWAV
$4.92M
$25.5K ﹤0.01%
18,472
LOCL icon
3963
Local Bounti
LOCL
$24.8M
$25.4K ﹤0.01%
19,664
BIAF icon
3964
bioAffinity Technologies
BIAF
$3.18M
$25.2K ﹤0.01%
31,071
ALZN icon
3965
Alzamend Neuro
ALZN
$7.57M
$25.2K ﹤0.01%
21,020
COCP icon
3966
Cocrystal Pharma
COCP
$21M
$25.2K ﹤0.01%
24,016
ACXP icon
3967
Acurx Pharmaceuticals
ACXP
$7.09M
$25.1K ﹤0.01%
16,205
PULM icon
3968
Pulmatrix
PULM
$5.7M
$25K ﹤0.01%
14,715
ORGN
3969
DELISTED
Origin Materials
ORGN
$25K ﹤0.01%
25,251
-3,653
-13% -$5.95K
CYCN icon
3970
Cyclerion Therapeutics
CYCN
$18.9M
$24.9K ﹤0.01%
7,353
MITQ icon
3971
Moving iMage Technologies
MITQ
$5.27M
$24.8K ﹤0.01%
42,755
KAPA
3972
Kairos Pharma
KAPA
$7.69M
$24.5K ﹤0.01%
63,884
AIFA
3973
All In FutureTech Alliance Inc
AIFA
$19.3M
$24.5K ﹤0.01%
10,971
-1
-0% -$3
XWEL icon
3974
XWELL
XWEL
$7.85M
$24.3K ﹤0.01%
23,380
XPON icon
3975
Expion360
XPON
$4.22M
$24K ﹤0.01%
4,447

Similar funds

Vanguard Fiduciary Trust's Q2 2026 Portfolio in Review

As of Q2 2026, Vanguard Fiduciary Trust held 4,173 positions worth $454B, up 15% from $396B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Fiduciary Trust opened 110 new positions and exited 97, leaving the 4,173-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.

  • Vanguard Fiduciary Trust's largest Q2 2026 buy was SpaceX: 3,791,999 shares worth $648M.
  • Vanguard Fiduciary Trust added most to Alphabet (Google) Class A in Q2 2026, an estimated $173M increase.
  • Vanguard Fiduciary Trust's biggest Q2 2026 reduction was Honeywell, cutting an estimated $401M.
  • Vanguard Fiduciary Trust fully exited Coterra Energy in Q2 2026, selling an estimated $149M.
  • Vanguard Fiduciary Trust's ten largest holdings make up 29% of its $454B portfolio in Q2 2026.
  • Vanguard Fiduciary Trust opened 110 new positions and closed 97 in Q2 2026.
  • Vanguard Fiduciary Trust's portfolio value rose 15% quarter-over-quarter to $454B.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.